deltatrials
Completed OBSERVATIONAL NCT02539329

Characterization of Anti-FGFR3 Antibodies

Characterization of Sensory Neuropathies Associated With Anti-FGFR3 Antibodies

Sponsor: Centre Hospitalier Universitaire de Saint Etienne

Conditions Sensory Peripheral Neuropathy
Interventions Neurological assessment and Blood sample
Updated 18 times since 2017 Last updated: Feb 9, 2023 Started: Feb 3, 2015 Primary completion: Nov 15, 2021 Completion: Jan 17, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Sensory Peripheral Neuropathy and is currently completed. Centre Hospitalier Universitaire de Saint Etienne leads this study, which shows 18 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Feb 2018 · 6 months · monthly snapshot~Feb 2018 – ~Mar 2018 · 28 days · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~May 2019 · 11 months · monthly snapshot~May 2019 – ~Oct 2019 · 5 months · monthly snapshot~Oct 2019 – ~Jun 2020 · 8 months · monthly snapshot~Jun 2020 – ~Nov 2020 · 5 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Dec 2021 · 6 months · monthly snapshot~Dec 2021 – ~Mar 2023 · 15 months · monthly snapshot~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Mar 2023 — Jul 2024 [monthly]

    Completed

    Status: Recruiting → Completed

  5. Dec 2021 — Mar 2023 [monthly]

    Recruiting

▶ Show 13 earlier versions

  1. Jun 2021 — Dec 2021 [monthly]

    Recruiting

  2. Jan 2021 — Jun 2021 [monthly]

    Recruiting

  3. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  4. Jun 2020 — Nov 2020 [monthly]

    Recruiting

  5. Oct 2019 — Jun 2020 [monthly]

    Recruiting

  6. May 2019 — Oct 2019 [monthly]

    Recruiting

  7. Jun 2018 — May 2019 [monthly]

    Recruiting

  8. May 2018 — Jun 2018 [monthly]

    Recruiting

  9. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  10. Mar 2018 — Apr 2018 [monthly]

    Recruiting NA

  11. Feb 2018 — Mar 2018 [monthly]

    Recruiting NA

  12. Aug 2017 — Feb 2018 [monthly]

    Recruiting NA

  13. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier Universitaire de Saint Etienne
Data source: Centre Hospitalier Universitaire de Saint Etienne

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bordeaux, France , Clermont-Ferrand, France , Créteil, France , Grenoble, France , Limoges, France , Lyon, France , Marseille, France , Nantes, France , Nice, France , Paris, France and 5 more locations